3 drug(s) with this reaction
686 total reports
Cardiac Failure has been reported as an adverse reaction across 3 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 686 adverse event reports mention cardiac failure in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with cardiac failure, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have cardiac failure listed in their FDA adverse event reports, sorted by report count:
In addition to cardiac failure, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
3 drug(s) manufactured by Abbvie Inc have cardiac failure listed in their FDA adverse event reports: PARICALCITOL, VENETOCLAX, SEVOFLURANE.
There are a combined 686 reports of cardiac failure across 3 Abbvie Inc drug(s) in the FDA adverse event database.